Genetic diagnosis of familial hypercholesterolemia in Han Chinese

Journal of Clinical Lipidology

Volumn 10, Issue 3, 2016, Pages 490-496

  Chiou, Kuan Rau ^a,b   Charng, Min Ji ^a,b  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Chinese; Familial hypercholesterolemia; Genetics; Low density lipoprotein receptor; Mutation

Indexed keywords

APOLIPOPROTEIN B; DNA; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN RECEPTOR;

ARTICLE; CARDIOVASCULAR RISK; CHINA; CHOLESTEROL BLOOD LEVEL; ECONOMIC DEVELOPMENT; FAMILIAL HYPERCHOLESTEROLEMIA; GENE REARRANGEMENT; GENETIC ANALYSIS; HAN CHINESE; HETEROZYGOTE; HONG KONG; HUMAN; MOLECULAR DIAGNOSIS; MOLECULAR GENETICS; POINT MUTATION; PRIORITY JOURNAL; SYSTEMATIC REVIEW; TAIWAN; ETHNIC GROUP; ETHNOLOGY; GENETICS; HYPERLIPOPROTEINEMIA TYPE II; METABOLISM; MUTATION; PHENOTYPE; PROCEDURES;

CHINA; ETHNIC GROUPS; HUMANS; HYPERLIPOPROTEINEMIA TYPE II; MOLECULAR DIAGNOSTIC TECHNIQUES; MUTATION; PHENOTYPE;

EID: 84962583682     PISSN: 19332874     EISSN: 18764789     Source Type: Journal    
DOI: 10.1016/j.jacl.2016.01.009     Document Type: Review

References (50)

1. M.S. Brown, and J.L. Goldstein A receptor-mediated pathway for cholesterol homeostasis Science 232 1986 34 37
2. L.F. Soria, E.H. Ludwig, H.R. Clarke, G.L. Vega, S.M. Grundy, and B.J. McCarthy Association between a specific apolipoprotein B mutation and familial defective apolipoprotein B-100 Proc Natl Acad Sci U S A 86 1989 587 591
3. M. Abifadel, M. Varret, J.P. Rabès, and et al. Mutations in PCSK9 cause autosomal dominant hypercholesterolemia Nat Genet 34 2003 154 156
4. M. Benn, G.F. Watts, A. Tybjaerg-Hansen, and B.G. Nordestgaard Familial hypercholesterolemia in the Danish general population: prevalence, coronary artery disease, and cholesterol-lowering medication J Clin Endocrinol Metab 97 2012 3956 3964
5. D. Marks, M. Thorogood, H.A. Neil, and S.E. Humphries A review on the diagnosis, natural history, and treatment of familial hypercholesterolaemia Atherosclerosis 168 2003 1 14
6. B.G. Nordestgaard, M.J. Chapman, S.E. Humphries, and et al. Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society Eur Heart J 34 2013 3478 3490
7. Z. Shi, B. Yuan, D. Zhao, A.W. Taylor, J. Lin, and G.F. Watts Familial hypercholesterolemia in China: prevalence and evidence of underdetection and undertreatment in a community population Int J Cardiol 174 2014 834 836
8. S.E. Leigh, A.H. Foster, R.A. Whittall, C.S. Hubbart, and S.E. Humphries Update and analysis of the University College London low density lipoprotein receptor familial hypercholesterolemia database Ann Hum Genet 72 2008 485 498
9. E. Usifo, S.E. Leigh, R.A. Whittall, and et al. Low-density lipoprotein receptor gene familial hypercholesterolemia variant database: update and pathological assessment Ann Hum Genet 76 2012 387 401
10. (website), JoJoGenetics. DNA Diagnostiek, 2014 (cited 31 December 2014); Available from: http://www.jojogenetics.nl.
11. J.T. den Dunnen, and S.E. Antonarakis Mutation nomenclature extensions and suggestions to describe complex mutations: a discussion Hum Mutat 15 2000 7 12
12. X.M. Sun, D.D. Patel, J.C. Webb, and et al. Familial hypercholesterolemia in China. Identification of mutations in the LDL-receptor gene that result in a receptor-negative phenotype Arterioscler Thromb 14 1994 85 94
13. Y.T. Mak, C.P. Pang, B. Tomlinson, and et al. Mutations in the low-density lipoprotein receptor gene in Chinese familial hypercholesterolemia patients Arterioscler Thromb Vasc Biol 18 1998 1600 1605
14. K.L. Khoo, P. van Acker, J.C. Defesche, and et al. Low-density lipoprotein receptor gene mutations in a Southeast Asian population with familial hypercholesterolemia Clin Genet 58 2000 98 105
15. J.H. Chang, J.P. Pan, D.Y. Tai, and et al. Identification and characterization of LDL receptor gene mutations in hyperlipidemic Chinese J Lipid Res 44 2003 1850 1858
16. M.J. Charng, K.R. Chiou, H.M. Chang, H.M. Cheng, Z.X. Ye, and S.J. Lin Identification and characterization of novel low-density lipoprotein receptor mutations of familial hypercholesterolaemia patients in Taiwan Eur J Clin Invest 36 2006 866 874
17. K.C. Yang, Y.N. Su, J.Y. Shew, and et al. LDLR and ApoB are major genetic causes of autosomal dominant hypercholesterolemia in a Taiwanese population J Formos Med Assoc 106 2007 799 807
18. K.R. Chiou, and M.J. Charng Detection of mutations and large rearrangements of the low-density lipoprotein receptor gene in Taiwanese patients with familial hypercholesterolemia Am J Cardiol 105 2010 1752 1758
19. D.Y. Tai, J.P. Pan, and G.J. Lee-Chen Identification and haplotype analysis of apolipoprotein B-100 Arg3500→Trp mutation in hyperlipidemic Chinese Clin Chem 44 1998 1659 1665
20. K.R. Chiou, and M.J. Charng Common mutations of familial hypercholesterolemia patients in Taiwan: characteristics and implications of migrations from southeast China Gene 498 1 2012 100 106
21. K. Chen, Y.M. Mu, B.A. Wang, and et al. Two novel mutations 685del 1 and D129G in the low-density lipoprotein receptor gene in a compound heterozygote Chinese family with familial hypercholesterolemia Metabolism 56 2007 636 640
22. L. Wang, J. Lin, S. Liu, and et al. Mutations in the LDL receptor gene in four Chinese homozygous familial hypercholesterolemia phenotype patients Nutr Metab Cardiovasc Dis 19 2009 391 400
23. Q.F. Pang, Y. Wang, M. Xu, L. Ding, W. Dong, and P.J. Mao Screening for low-density lipoprotein receptor gene mutations in familial hypercholesterolemia Chinese Zhonghua Nei Ke Za Zhi 43 2004 665 668
24. H. Wang, S. Xu, L. Sun, X. Pan, S. Yang, and L. Wang Functional characterization of two low-density lipoprotein receptor gene mutations in two Chinese patients with familial hypercholesterolemia PLoS One 9 2014 e92703
25. K.R. Chiou, M.J. Charng, and H.M. Chang Array-based resequencing for mutations causing familial hypercholesterolemia Atherosclerosis 216 2011 383 389
26. L. Jiang, F. Gao, L.B. Hu, and et al. Seven-year clinical follow-up of Chinese homozygous familial hypercholesterolemia child with premature xanthomas and coronary artery disease-A need for early diagnosis and aggressive treatment Int J Cardiol 177 2014 188 191
27. W.F. Wu, L.Y. Sun, X.D. Pan, S.W. Yang, and L.Y. Wang Use of targeted exome sequencing in genetic diagnosis of Chinese familial hypercholesterolemia PLoS One 9 2014 e94697
28. L.L. Fan, M.J. Lin, Y.Q. Chen, and et al. Novel mutations of low-density lipoprotein receptor gene in China patients with familial hypercholesterolemia Appl Biochem Biotechnol 176 2015 101 109
29. D.M. Kusters, R. Huijgen, J.C. Defesche, and et al. Founder mutations in the Netherlands: geographical distribution of the most prevalent mutations in the low-density lipoprotein receptor and apolipoprotein B genes Neth Heart J 19 2011 175 182
30. L. Palacios, L. Grandoso, N. Cuevas, and et al. Molecular characterization of familial hypercholesterolemia in Spain Atherosclerosis 221 2012 137 142
31. J.C. Defesche, M.A. van de Ree, J.J. Kastelein, and et al. Detection of the Pro664-Leu mutation in the low-density lipoprotein receptor and its relation to lipoprotein(a) levels in patients with familial hypercholesterolemia of Dutch ancestry from The Netherlands and Canada Clin Genet 42 1992 273 280
32. H. Mabuchi, A. Nohara, T. Noguchi, and et al. Genotypic and phenotypic features in homozygous familial hypercholesterolemia caused by proprotein convertase subtilisin/kexin type 9 (PCSK9) gain-of-function mutation Atherosclerosis 236 2014 54 61
33. J. Lin, L.Y. Wang, S. Liu, and et al. A novel mutation in proprotein convertase subtilisin/kexin type 9 gene leads to familial hypercholesterolemia in a Chinese family Chin Med J (Engl) 123 2010 1133 1138
34. H.J. Cai, L.M. Fan, M.G. Huang, X.Y. Chen, G.Q. Liu, and Q. Chen Homozygous familial hypercholesterolemic patients in China Atherosclerosis 57 1985 303 312
35. S.N. Pimstone, X.M. Sun, C. du Souich, J.J. Frohlich, M.R. Hayden, and A.K. Soutar Phenotypic variation in heterozygous familial hypercholesterolemia: a comparison of Chinese patients with the same or similar mutations in the LDL receptor gene in China or Canada Arterioscler Thromb Vasc Biol 18 1998 309 315
36. T.O. Cheng Rising cholesterol levels in China Int J Cardiol 105 2005 332 333
37. Y.H. Li, Y. Li, C.E. Davis, and et al. Serum cholesterol changes from 1983-1984 to 1993-1994 in the People's Republic of China Nutr Metab Cardiovasc Dis 12 2002 118 126
38. J. He, D. Gu, K. Reynolds, and et al. Serum total and lipoprotein cholesterol levels and awareness, treatment, and control of hypercholesterolemia in China Circulation 110 2004 405 411
39. L.D. Wong The 2002 China National Nutrition and Health Survey (1): General Report 2005 People Health Publishing House Beijing
40. W. Yang, J. Xiao, Z. Yang, and et al. Serum lipids and lipoproteins in Chinese men and women Circulation 125 2012 2212 2221
41. A. Sekikawa, Y. Miyamoto, K. Miura, and et al. Continuous decline in mortality from coronary heart disease in Japan despite a continuous and marked rise in total cholesterol: Japanese experience after the Seven Countries Study Int J Epidemiol 44 2015 1614 1624
42. M.M. Motazacker, J. Pirruccello, R. Huijgen, and et al. Advances in genetics show the need for extending screening strategies for autosomal dominant hypercholesterolaemia Eur Heart J 33 2012 1360 1366
43. A.C. Alves, A. Etxebarria, A.K. Soutar, C. Martin, and M. Bourbon Novel functional APOB mutations outside LDL-binding region causing familial hypercholesterolaemia Hum Mol Genet 23 2014 1817 1828
44. M. Hu, W. Lan, C.W. Lam, Y.T. Mak, C.P. Pang, and B. Tomlinson Heterozygous familial hypercholesterolemia in Hong Kong Chinese. Study of 252 cases Int J Cardiol 167 2013 762 767
45. J. Pang, D.R. Sullivan, M. Harada-Shiba, and et al. Significant gaps in awareness of familial hypercholesterolemia among physicians in selected Asia-Pacific countries: a pilot study J Clin Lipidol 9 2015 42 48
46. C.H. Huang, P.C. Chiu, H.C. Liu, and et al. Clinical observations and treatment of pediatric homozygous familial hypercholesterolemia due to a low-density lipoprotein receptor defect J Clin Lipidol 9 2015 234 240
47. J.A. Marbach, J.L. McKeon, J.L. Ross, and D. Duffy Novel treatments for familial hypercholesterolemia: pharmacogenetics at work Pharmacotherapy 34 2014 961 972
48. M.A. Umans-Eckenhausen, J.C. Defesche, E.J. Sijbrands, R.L. Scheerder, and J.J. Kastelein Review of first 5 years of screening for familial hypercholesterolaemia in the Netherlands Lancet 357 2001 165 168
49. C.E. Jannes, R.D. Santos, P.R. de Souza Silva, and et al. Familial hypercholesterolemia in Brazil: cascade screening program, clinical and genetic aspects Atherosclerosis 238 2015 101 107
50. E.C. O'Brien, M.T. Roe, E.S. Fraulo, and et al. Rationale and design of the familial hypercholesterolemia foundation CAscade SCreening for Awareness and DEtection of Familial Hypercholesterolemia registry Am Heart J 167 2014 342 349